Login or Signup to Mondaq.com to recieve our newsletter

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

What To Build—and Where—in 2026: Healthcare Real Estate Strategy Forecast

Ankura's Healthcare Real Estate Solutions team tracks critical economic, regulatory, and market trends to guide strategic investment decisions that will define capital allocation...

United States Healthcare

AC

Ankura Consulting Group LLC

LEAD-ing The Future Of ACOs: New Long-term Enhanced ACO Design Model

The Centers for Medicare & Medicaid Services (CMS) Innovation Center has announced the Long-term Enhanced ACO Design (LEAD) Model — a 10-year initiative designed to advance...

United States Healthcare

FL

Foley & Lardner

Required HIPAA Notice Of Privacy Practices Changes Due

Most covered entities are required to provide the Notice to patients, try to obtain acknowledgement of receipt, display it at their service locations and "prominently post" it on their websites.

United States Healthcare

HK

Holland & Knight

FDA Finds "Significant Data Gaps" For PFAS Used In Cosmetic Products

As required under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), on December 29, 2025, the U.S. Food and Drug Administration (FDA) published a Report on the Use of PFAS in Cosmetic Products and Associated Risks.

United States Healthcare

BC

Bergeson & Campbell

Prescribing/Dispensing "Outside The Usual Course Of Professional Practice:" Trend, Coincidence Or Passing Fancy?

United States Healthcare

HP

Hyman, Phelps, & McNamara

MFN Drug Pricing Update: After GENEROUS, GUARD And GLOBE Issue From CMS's Innovation Center – Part II

Worldwide Healthcare

HP

Hyman, Phelps, & McNamara

Food Industry Groups Challenge Texas Law Requiring Warning Labels For Certain Food Ingredients

United States Healthcare

BD

Beveridge & Diamond

PE's Healthcare Playbook Is Challenged — And 2026 Will Be A Reckoning

United States Healthcare

R

Riveron

FDA Explains Its Mandatory Cosmetics Recall Authority, Adhering Closely To 2022 Statutory Language

United States Healthcare

WR

Wiley Rein

CMS And FDA Unveil A Digital Health Pilot For Chronic Conditions

United States Healthcare

GT

Greenberg Traurig, LLP

IDPH Issues Submission Guidance Via The SIREN Notification System On Illinois Health Care Sanctity And Privacy Law Requiring Hospitals To Adopt And Submit Policies Regarding Law Enforcement Interactions

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

United States Healthcare

FL

Foley & Lardner

CMS ACCESS Model: Providers Prepare For Technology-Driven, Value-Based Care

United States Healthcare

FL

Foley & Lardner

The BALANCE Model And A New Wave Of CMS Drug Pricing Models

United States Healthcare

M

Mintz

See more

Webinars

See More

20 Jan 2026 | 3:00 PM

2026 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CBA In-House Lawyers

TC

CBA In-House Lawyers

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Healthcare

What To Build—and Where—in 2026: Healthcare Real Estate Strategy Forecast

Ankura's Healthcare Real Estate Solutions team tracks critical economic, regulatory, and market trends to guide strategic investment decisions that will define capital allocation...

United States Healthcare

AC

Ankura Consulting Group LLC

LEAD-ing The Future Of ACOs: New Long-term Enhanced ACO Design Model

The Centers for Medicare & Medicaid Services (CMS) Innovation Center has announced the Long-term Enhanced ACO Design (LEAD) Model — a 10-year initiative designed to advance...

United States Healthcare

FL

Foley & Lardner

Required HIPAA Notice Of Privacy Practices Changes Due

Most covered entities are required to provide the Notice to patients, try to obtain acknowledgement of receipt, display it at their service locations and "prominently post" it on their websites.

United States Healthcare

HK

Holland & Knight

Excess Forecast: Five Warning Signs A Routine Claim Is About To Escalate

United States Commercial

FB

FBT Gibbons

Prescribing/Dispensing "Outside The Usual Course Of Professional Practice:" Trend, Coincidence Or Passing Fancy?

United States Healthcare

HP

Hyman, Phelps, & McNamara

Food Industry Groups Challenge Texas Law Requiring Warning Labels For Certain Food Ingredients

United States Healthcare

BD

Beveridge & Diamond

PE's Healthcare Playbook Is Challenged — And 2026 Will Be A Reckoning

United States Healthcare

R

Riveron

CMS And FDA Unveil A Digital Health Pilot For Chronic Conditions

United States Healthcare

GT

Greenberg Traurig, LLP

IDPH Issues Submission Guidance Via The SIREN Notification System On Illinois Health Care Sanctity And Privacy Law Requiring Hospitals To Adopt And Submit Policies Regarding Law Enforcement Interactions

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

See more

Food and Drugs Law

What To Build—and Where—in 2026: Healthcare Real Estate Strategy Forecast

Ankura's Healthcare Real Estate Solutions team tracks critical economic, regulatory, and market trends to guide strategic investment decisions that will define capital allocation...

United States Healthcare

AC

Ankura Consulting Group LLC

FDA Finds "Significant Data Gaps" For PFAS Used In Cosmetic Products

As required under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), on December 29, 2025, the U.S. Food and Drug Administration (FDA) published a Report on the Use of PFAS in Cosmetic Products and Associated Risks.

United States Healthcare

BC

Bergeson & Campbell

Excess Forecast: Five Warning Signs A Routine Claim Is About To Escalate

Excess carriers face a unique challenge: estimating where a potentially high-value claim will end up before most of the pertinent facts have come to light

United States Commercial

FB

FBT Gibbons

Prescribing/Dispensing "Outside The Usual Course Of Professional Practice:" Trend, Coincidence Or Passing Fancy?

United States Healthcare

HP

Hyman, Phelps, & McNamara

MFN Drug Pricing Update: After GENEROUS, GUARD And GLOBE Issue From CMS's Innovation Center – Part II

Worldwide Healthcare

HP

Hyman, Phelps, & McNamara

Food Industry Groups Challenge Texas Law Requiring Warning Labels For Certain Food Ingredients

United States Healthcare

BD

Beveridge & Diamond

FDA Explains Its Mandatory Cosmetics Recall Authority, Adhering Closely To 2022 Statutory Language

United States Healthcare

WR

Wiley Rein

CMS And FDA Unveil A Digital Health Pilot For Chronic Conditions

United States Healthcare

GT

Greenberg Traurig, LLP

The BALANCE Model And A New Wave Of CMS Drug Pricing Models

United States Healthcare

M

Mintz

See more

Life Sciences, Biotechnology & Nanotechnology

Prescribing/Dispensing "Outside The Usual Course Of Professional Practice:" Trend, Coincidence Or Passing Fancy?

We follow the civil settlements agreed to by the Drug Enforcement Administration ("DEA") and registrants that are announced in press releases by U.S. Attorney's Offices and DEA.

United States Healthcare

HP

Hyman, Phelps, & McNamara

Food Industry Groups Challenge Texas Law Requiring Warning Labels For Certain Food Ingredients

A Make America Healthy Again (MAHA)-inspired state law mandating that food containing any of 44 ingredients bear a label with the above statement, is now the subject of a federal district court challenge.

United States Healthcare

BD

Beveridge & Diamond

PE's Healthcare Playbook Is Challenged — And 2026 Will Be A Reckoning

Heading into 2026, private equity sponsors are now confronting a reality the industry has avoided for a decade: the traditional value-creation playbook in healthcare and life sciences is under significant pressure.

United States Healthcare

R

Riveron

CMS And FDA Unveil A Digital Health Pilot For Chronic Conditions

United States Healthcare

GT

Greenberg Traurig, LLP

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

United States Healthcare

FL

Foley & Lardner

The BALANCE Model And A New Wave Of CMS Drug Pricing Models

United States Healthcare

M

Mintz

Virtual And Digital Health Digest - December 2025

Worldwide Healthcare

AP

Arnold & Porter

When FDA Can Make You Recall That Mascara

United States Healthcare

HP

Hyman, Phelps, & McNamara

S1 E10: As 2026 Approaches, Here's What To Watch (Podcast)

United States Healthcare

PL

Polsinelli LLP

See more

Latest Videos

See more

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

FL

Foley & Lardner

Strategic Synergy At Atlantic Health: Saad Ehtisham On How Leadership Alignment Fuels Transformation (Video)

AM

Alvarez & Marsal

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

WHLC Summit - Day One Recording (Video)

SM

Sheppard Mullin Richter & Hampton

Upcoming Events

Healthcare Innovation: Strategic Adaption To The New Policy Landscape

United States Healthcare

FH

Foley Hoag LLP

Arnold & Porter’s 2026 Life Sciences Future Forum

United States Healthcare

AP

Arnold & Porter

The Town Hall Table: From State Chapters To The U.S. Capitol

United States Healthcare

HK

Holland & Knight

Join Arnold & Porter’s Global Life Sciences Industry Group During The J.P. Morgan Healthcare Conference

United States Healthcare

AP

Arnold & Porter

Pharmaceutical EHS Counsel Roundtable

United States Healthcare

BD

Beveridge & Diamond

All In The Family - After The Wedding: AMC And Community Hospital Affiliations In Practice - American Health Law Association Academic Medical Centers Conference

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Pestalozzi At The J.P. Morgan Healthcare Conference 2026

United States Healthcare

PL

Pestalozzi Attorneys at Law

The Mass League Health Center Compliance Academy: Pharmacy/340B

United States Healthcare

FH

Foley Hoag LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More